Cambridge Trust’s Ingevity NGVT Stock Holding History

Cambridge Trust’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2	Closed	–	–	846
2022 Q3	$0	Buy	+2	New	+$134	﹤0.01%	878
2022 Q1	–	Sell	-7	Closed	-$1K	–	1078
2021 Q4	$1K	Buy	+7	New	+$532	﹤0.01%	1008

Other funds holding NGVT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ICP

Inclusive Capital Partners San Francisco, California $26M AUM 22.24% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BBCM

Broad Bay Capital Management New York $1.18B AUM 65.45% 1-Year Est. Return

MRCP

Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return

Cambridge Trust's NGVT Position: Q4 2022 in Review

Cambridge Trust sold out of Ingevity (NGVT) in Q4 2022, closing a stake of 2 shares.

Cambridge Trust first reported a position in NGVT in Q4 2021 and held it in 2 quarters. The position peaked at $1K in Q4 2021. 293 funds tracked by Wall St. Rank hold NGVT as of Q4 2022.

Cambridge Trust reported no remaining Ingevity position as of Q4 2022 after selling out during the quarter.
Cambridge Trust sold 2 Ingevity shares in Q4 2022.
Cambridge Trust first reported a position in Ingevity in Q4 2021 and held it in 2 quarters.
Cambridge Trust's Ingevity position peaked at $1K in Q4 2021.
293 funds tracked by Wall St. Rank held Ingevity as of Q4 2022.

Based on Cambridge Trust's 13F filing for Q4 2022, filed 10 Jan 2023.